Rhythm Pharmaceuticals buy JPMorgan Chase & Co.
Start price
27.07.26
/
50%
€90.00
Target price
27.07.27
€127.17
Performance (%)
0.56%
Price
05.08.26
€90.50
Summary
This prediction is currently active. Since the start of the prediction for Rhythm Pharmaceuticals the price has only changed by 0.56%. This prediction currently runs until 27.07.27. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Rhythm Pharmaceuticals | -2.162% |
| iShares Core DAX® | 3,15 % |
| iShares Nasdaq 100 | 7,43 % |
| iShares Nikkei 225® | 8,57 % |
| iShares S&P 500 | 4,58 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals (RYTM) is now covered by JPMorgan Chase & Co.. They set an "overweight" rating and a $145.00 price target on the stock.
Ratings data for RYTM provided by MarketBeat